Skip to content

Editas CEO Katrine Bosley Predicts First CRISPR Human Trial in 2017 | MIT Technology Review

November 6, 2015

A biotechnology company says it will test advanced gene-engineering methods to treat blindness.

Sourced through Scoop.it from: www.technologyreview.com

CRISPR to treat a rare eye diseases in humans, starting in 2017.

See on Scoop.itLong Life

Advertisements
No comments yet

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: